In addition to being commonly detected in PDAC [2], these mutations are also found in the earliest stages of this disease [4] and, when introduced into the murine Kras gene, induce early stage pancreatic cancer that can progress to frank PDAC [5]. Here, KRAS is linked to pancreatic neoplasm.